TapewireFind a company

person · Reporting owner

MANSBACH MICHAEL JOSEPH

Disclosed activity across 2 companies

Tapewire entity
73031
SEC CIK
0001272466

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
REGIS CORPRGS · Entity 8808DirectorNovember 14, 2025November 18, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

REGIS CORP

Report date November 14, 2025 · Filed November 18, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect8,114 Reported balance After 2025-11-14 transaction · row 1
1 source row

Row 1 · 2025-11-14 · Grant · Acquired 2,727 · Balance 8,114

F1: The award vests on the earlier of November 14, 2026 or the Issuer's next annual meeting of shareholders after November 14, 2025, subject to the Reporting Person's continued service to the Issuer through such vesting date and the other terms and conditions of the grant agreements.

Filing footnotes · ownership attribution and instrument terms

F1: The award vests on the earlier of November 14, 2026 or the Issuer's next annual meeting of shareholders after November 14, 2025, subject to the Reporting Person's continued service to the Issuer through such vesting date and the other terms and conditions of the grant agreements.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

MINDBODY, Inc.

Report date February 15, 2019 · Filed February 20, 2019

Section 16 reporting ended · disclosed 2019-02-20. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2019-02-15 transaction · row 1
1 source row

Row 1 · 2019-02-15 · Disposition to issuer · Disposed 120,046 · Balance 0

F1: Includes 115,380 unvested restricted stock units ("RSUs").

F2: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated December 23, 2018, by and among MINDBODY, Inc., a Delaware corporation (the "Issuer"), Torreys Parent, LLC ("Parent"), and Torreys Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), on February 15, 2019, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent. Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of the unvested RSUs was cancelled and replaced with the right to receive $36.50 in cash, without interest, subject to the Reporting Person's continued service with Parent and its affiliates (including the Issuer and its subsidiaries) through the applicable vesting dates, which payment shall be made on the same vesting schedule and subject to the same terms and conditions as the unvested RSUs would have been.

F3: In connection with the Merger, each share of Class A Common Stock was cancelled and converted into the right to receive $36.50 in cash, without interest, per share, subject to the terms and conditions of the Merger Agreement.

Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.05 · Expires 2027-08-21Direct0 Reported balance After 2019-02-15 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2019-02-15 · Disposition to issuer · Disposed 102,224 · Balance 0

F5: Includes 36,204 vested options and 66,020 unvested options.

F6: At the Effective Time, each of the unvested options was cancelled and and replaced with the right to receive a cash payment equal to the product of (i) the aggregate number of shares subject to such option, multiplied by (ii) $36.50 less the applicable per share exercise price under such option, subject to any applicable withholding taxes, which cash payment will, subject to the Reporting Person's continued service with Parent and its affiliates (including the Issuer and its subsidiaries) through the applicable vesting dates, vest and be payable at the same time as the unvested option would have vested.

F7: At the Effective Time, each of these vested options was cancelled and automatically converted into the right to receive a cash payment equal to the product of (i) the aggregate number of shares subject to such option, multiplied by (ii) $36.50 less the applicable per share exercise price under such option, subject to any applicable withholding taxes.

F4: 1/4 of the shares subject to the option vested on August 21, 2018, and 1/48 of the shares vest monthly thereafter.

Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.45 · Expires 2028-02-20Direct0 Reported balance After 2019-02-15 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2019-02-15 · Disposition to issuer · Disposed 31,240 · Balance 0

F6: At the Effective Time, each of the unvested options was cancelled and and replaced with the right to receive a cash payment equal to the product of (i) the aggregate number of shares subject to such option, multiplied by (ii) $36.50 less the applicable per share exercise price under such option, subject to any applicable withholding taxes, which cash payment will, subject to the Reporting Person's continued service with Parent and its affiliates (including the Issuer and its subsidiaries) through the applicable vesting dates, vest and be payable at the same time as the unvested option would have vested.

F8: 1/4 of the shares subject to the option vest on February 20, 2019, and 1/48 of the shares vest monthly thereafter.

Filing footnotes · ownership attribution and instrument terms

F1: Includes 115,380 unvested restricted stock units ("RSUs").

F2: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated December 23, 2018, by and among MINDBODY, Inc., a Delaware corporation (the "Issuer"), Torreys Parent, LLC ("Parent"), and Torreys Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), on February 15, 2019, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent. Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of the unvested RSUs was cancelled and replaced with the right to receive $36.50 in cash, without interest, subject to the Reporting Person's continued service with Parent and its affiliates (including the Issuer and its subsidiaries) through the applicable vesting dates, which payment shall be made on the same vesting schedule and subject to the same terms and conditions as the unvested RSUs would have been.

F3: In connection with the Merger, each share of Class A Common Stock was cancelled and converted into the right to receive $36.50 in cash, without interest, per share, subject to the terms and conditions of the Merger Agreement.

F4: 1/4 of the shares subject to the option vested on August 21, 2018, and 1/48 of the shares vest monthly thereafter.

F5: Includes 36,204 vested options and 66,020 unvested options.

F6: At the Effective Time, each of the unvested options was cancelled and and replaced with the right to receive a cash payment equal to the product of (i) the aggregate number of shares subject to such option, multiplied by (ii) $36.50 less the applicable per share exercise price under such option, subject to any applicable withholding taxes, which cash payment will, subject to the Reporting Person's continued service with Parent and its affiliates (including the Issuer and its subsidiaries) through the applicable vesting dates, vest and be payable at the same time as the unvested option would have vested.

F7: At the Effective Time, each of these vested options was cancelled and automatically converted into the right to receive a cash payment equal to the product of (i) the aggregate number of shares subject to such option, multiplied by (ii) $36.50 less the applicable per share exercise price under such option, subject to any applicable withholding taxes.

F8: 1/4 of the shares subject to the option vest on February 20, 2019, and 1/48 of the shares vest monthly thereafter.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
November 14, 2025 Filed Nov 18, 2025 22:01 UTC REGIS CORP RGS · Entity 8808 GrantCommon Stock 2,727 $0.00 $0.00
Disclosure

SEC source: 0001272466-25-000005 · form4-11182025_101100.xml · nonDerivative · entry 1

MANSBACH MICHAEL JOSEPH · CIK 0001272466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,114

F1 · shares: The award vests on the earlier of November 14, 2026 or the Issuer's next annual meeting of shareholders after November 14, 2025, subject to the Reporting Person's continued service to the Issuer through such vesting date and the other terms and conditions of the grant agreements.

Read SEC document
November 25, 2024 Filed Nov 26, 2024 22:15 UTC REGIS CORP RGS · Entity 8808 GrantCommon Stock 3,200 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-027754 · form4-11262024_101153.xml · nonDerivative · entry 1

MANSBACH MICHAEL JOSEPH · CIK 0001272466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,387

F1 · shares: The award vests on the earlier of November 25, 2025 or the Issuer's next annual meeting of shareholders after November 25, 2024, subject to the Reporting Person's continued service to the Issuer through such vesting date and the other terms and conditions of the grant agreements.

F2 · balance_after: Previous number of shares beneficially owned, 43,767, adjusted for 1-for-20 reverse stock split, to 2,187.

Read SEC document
November 04, 2022 Filed Nov 7, 2022 22:18 UTC REGIS CORP RGS · Entity 8808 GrantStock Options · Derivative 90,000 $0.00 Strike: $1.31 $0.00
Disclosure

SEC source: 0000716643-22-000081 · wf-form4_166785951369244.xml · derivative · entry 1

MANSBACH MICHAEL JOSEPH · CIK 0001272466 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2032-11-04

F1 · derivative.exercise_date: The award vests as to 1/12 of the stock options on each monthly anniversary of the grant date, for the first 11 months, and as to any remaining unvested stock options on the date of the Company's 2023 annual shareholders meeting, subject to the Reporting Person's continued service with the Issuer through such anniversaries and the other terms and conditions of the grant agreement

Read SEC document
November 05, 2021 Filed Nov 9, 2021 21:45 UTC REGIS CORP RGS · Entity 8808 GrantCommon Stock 39,855 $0.00 $0.00
Disclosure

SEC source: 0000716643-21-000092 · wf-form4_163649432380559.xml · nonDerivative · entry 1

MANSBACH MICHAEL JOSEPH · CIK 0001272466 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,767

F1 · shares: The Reporting Person was awarded a grant of 39,855 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of RGS common stock.

Read SEC document
June 14, 2021 Filed Jun 16, 2021 20:05 UTC REGIS CORP RGS · Entity 8808 GrantCommon Stock 3,912 $0.00 $0.00
Disclosure

SEC source: 0001179110-21-006775 · edgar.xml · nonDerivative · entry 1

MANSBACH MICHAEL JOSEPH · CIK 0001272466 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,912

F1 · shares: The Reporting Person was awarded a grant of 3,912 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of RGS common stock.

Read SEC document
February 15, 2019 Filed Feb 20, 2019 21:05 UTC MINDBODY, Inc. MB · Entity 160063 Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 31,240 Not disclosed Strike: $33.45 Not disclosed
Disclosure

SEC source: 0001209191-19-011856 · doc4.xml · derivative · entry 3

MANSBACH MICHAEL JOSEPH · CIK 0001272466 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 31,240 shares

Expires 2028-02-20

F6 · price: At the Effective Time, each of the unvested options was cancelled and and replaced with the right to receive a cash payment equal to the product of (i) the aggregate number of shares subject to such option, multiplied by (ii) $36.50 less the applicable per share exercise price under such option, subject to any applicable withholding taxes, which cash payment will, subject to the Reporting Person's continued service with Parent and its affiliates (including the Issuer and its subsidiaries) through the applicable vesting dates, vest and be payable at the same time as the unvested option would have vested.

F8 · derivative.exercise_date: 1/4 of the shares subject to the option vest on February 20, 2019, and 1/48 of the shares vest monthly thereafter.

Read SEC document
February 15, 2019 Filed Feb 20, 2019 21:05 UTC MINDBODY, Inc. MB · Entity 160063 Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 102,224 Not disclosed Strike: $23.05 Not disclosed
Disclosure

SEC source: 0001209191-19-011856 · doc4.xml · derivative · entry 2

MANSBACH MICHAEL JOSEPH · CIK 0001272466 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 102,224 shares

Expires 2027-08-21

F5 · price: Includes 36,204 vested options and 66,020 unvested options.

F6 · price: At the Effective Time, each of the unvested options was cancelled and and replaced with the right to receive a cash payment equal to the product of (i) the aggregate number of shares subject to such option, multiplied by (ii) $36.50 less the applicable per share exercise price under such option, subject to any applicable withholding taxes, which cash payment will, subject to the Reporting Person's continued service with Parent and its affiliates (including the Issuer and its subsidiaries) through the applicable vesting dates, vest and be payable at the same time as the unvested option would have vested.

F7 · price: At the Effective Time, each of these vested options was cancelled and automatically converted into the right to receive a cash payment equal to the product of (i) the aggregate number of shares subject to such option, multiplied by (ii) $36.50 less the applicable per share exercise price under such option, subject to any applicable withholding taxes.

F4 · derivative.exercise_date: 1/4 of the shares subject to the option vested on August 21, 2018, and 1/48 of the shares vest monthly thereafter.

Read SEC document
February 15, 2019 Filed Feb 20, 2019 21:05 UTC MINDBODY, Inc. MB · Entity 160063 Disposition to issuerClass A Common Stock 120,046 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-011856 · doc4.xml · nonDerivative · entry 1

MANSBACH MICHAEL JOSEPH · CIK 0001272466 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · shares: Includes 115,380 unvested restricted stock units ("RSUs").

F2 · shares: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated December 23, 2018, by and among MINDBODY, Inc., a Delaware corporation (the "Issuer"), Torreys Parent, LLC ("Parent"), and Torreys Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), on February 15, 2019, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent. Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of the unvested RSUs was cancelled and replaced with the right to receive $36.50 in cash, without interest, subject to the Reporting Person's continued service with Parent and its affiliates (including the Issuer and its subsidiaries) through the applicable vesting dates, which payment shall be made on the same vesting schedule and subject to the same terms and conditions as the unvested RSUs would have been.

F2 · price: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated December 23, 2018, by and among MINDBODY, Inc., a Delaware corporation (the "Issuer"), Torreys Parent, LLC ("Parent"), and Torreys Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), on February 15, 2019, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent. Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of the unvested RSUs was cancelled and replaced with the right to receive $36.50 in cash, without interest, subject to the Reporting Person's continued service with Parent and its affiliates (including the Issuer and its subsidiaries) through the applicable vesting dates, which payment shall be made on the same vesting schedule and subject to the same terms and conditions as the unvested RSUs would have been.

F3 · price: In connection with the Merger, each share of Class A Common Stock was cancelled and converted into the right to receive $36.50 in cash, without interest, per share, subject to the terms and conditions of the Merger Agreement.

Read SEC document
February 12, 2019 Filed Feb 14, 2019 18:04 UTC MINDBODY, Inc. MB · Entity 160063 GrantClass A Common Stock 961 $30.30 $29,120.70
Disclosure

SEC source: 0001209191-19-010376 · doc4.xml · nonDerivative · entry 1

MANSBACH MICHAEL JOSEPH · CIK 0001272466 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,046

F1 · shares: Represents 961 shares of Class A Common Stock acquired under the MINDBODY, Inc. 2015 Employee Stock Purchase Plan on February 12, 2019.

F2 · balance_after: Includes 115,380 restricted stock units ("RSUs"), where each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

F3 · balance_after: This amount includes the correction of a typographical error, which inadvertently stated the Reporting Person's holdings as 19,085 shares held instead of 119,085 shares held, in the previously filed Form 4.

Read SEC document
February 01, 2019 Filed Feb 5, 2019 19:26 UTC MINDBODY, Inc. MB · Entity 160063 GrantClass A Common Stock 41,095 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-007536 · doc4.xml · nonDerivative · entry 1

MANSBACH MICHAEL JOSEPH · CIK 0001272466 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,085

F1 · shares: The reported securities represent an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. Subject to the Reporting Person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the RSUs subject to the award will vest as follows: one-fourth (1/4th) of the RSUs will vest on February 20, 2020, and one-fourth (1/4th) of the RSUs will vest on each successive February 20 thereafter (or, if the 20th day of the month is not a market trading day, then the vesting date will be the first trading day following the 20th day of the month).

F2 · balance_after: Includes 74,285 RSUs, where each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

Read SEC document
August 21, 2018 Filed Aug 22, 2018 17:48 UTC MINDBODY, Inc. MB · Entity 160063 SaleClass A Common Stock 3,705 $35.25 $130,601.25
Disclosure

SEC source: 0001209191-18-048034 · doc4.xml · nonDerivative · entry 2

MANSBACH MICHAEL JOSEPH · CIK 0001272466 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,990

F4 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.50, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

F3 · balance_after: Includes 74,285 RSUs, where each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

Read SEC document
August 20, 2018 Filed Aug 22, 2018 17:48 UTC MINDBODY, Inc. MB · Entity 160063 Tax withholdingClass A Common Stock 3,918 $34.80 $136,346.40
Disclosure

SEC source: 0001209191-18-048034 · doc4.xml · nonDerivative · entry 1

MANSBACH MICHAEL JOSEPH · CIK 0001272466 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,695

F1 · kind: Shares withheld by the Issuer to satisfy the Issuer's tax withholding obligation in connection with the Reporting Person's vesting of restricted stock units ("RSUs").

F2 · shares: The number of shares withheld by the Issuer in connection with the vesting of RSUs was based on the closing price of the Issuer's Class A Common Stock on the vest date, pursuant to the terms of the 2015 Equity Incentive Plan.

F3 · balance_after: Includes 74,285 RSUs, where each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

Read SEC document
February 20, 2018 Filed Feb 22, 2018 19:29 UTC MINDBODY, Inc. MB · Entity 160063 GrantStock Option (right to buy) · Derivative 31,240 $0.00 Strike: $33.45 $0.00
Disclosure

SEC source: 0001209191-18-012727 · doc4.xml · derivative · entry 2

MANSBACH MICHAEL JOSEPH · CIK 0001272466 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,240

Underlying: Class A Common Stock · 31,240 shares

Expires 2028-02-20

F3 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option will vest on February 20, 2019, and one forty-eighth (1/48th) of the total shares subject to the option will vest monthly thereafter, subject to the Reporting Person continuing to be a Service Provider through each applicable vesting date.

Read SEC document
February 20, 2018 Filed Feb 22, 2018 19:29 UTC MINDBODY, Inc. MB · Entity 160063 GrantClass A Common Stock 40,299 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-012727 · doc4.xml · nonDerivative · entry 1

MANSBACH MICHAEL JOSEPH · CIK 0001272466 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,613

F1 · shares: The reported securities represent an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. Subject to the Reporting Person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the RSUs subject to the award will vest as follows: one-fourth (1/4th) of the RSUs will vest on February 20, 2019, and one-fourth (1/4th) of the RSUs will vest on each successive February 20 thereafter (or, if the 20th day of the month is not a market trading day, then the vesting date will be the first trading day following the 20th day of the month).

F2 · balance_after: Includes 45,314 RSUs, where each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement.

Read SEC document
August 21, 2017 Filed Aug 23, 2017 17:19 UTC MINDBODY, Inc. MB · Entity 160063 GrantEmployee Stock Option (right to buy) · Derivative 102,224 $0.00 Strike: $23.05 $0.00
Disclosure

SEC source: 0001209191-17-049984 · doc4.xml · derivative · entry 2

MANSBACH MICHAEL JOSEPH · CIK 0001272466 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,224

Underlying: Class A Common Stock · 102,224 shares

Expires 2027-08-21

F2 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option will vest on August 20, 2018, and one forty-eighth (1/48th) of the total shares subject to the option will vest monthly thereafter, subject to the Reporting Person continuing to be a Service Provider through each applicable vesting date.

Read SEC document
August 21, 2017 Filed Aug 23, 2017 17:19 UTC MINDBODY, Inc. MB · Entity 160063 GrantClass A Common Stock 45,314 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-049984 · doc4.xml · nonDerivative · entry 1

MANSBACH MICHAEL JOSEPH · CIK 0001272466 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,314

F1 · shares: The reported securities represent an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. Subject to the Reporting Person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the RSUs subject to the award will vest as follows: one-fourth (1/4th) of the RSUs will vest on August 20, 2018, and one-fourth (1/4th) of the RSUs will vest on each successive August 20 thereafter (or, if the 20th day of the month is not a market trading day, then the vesting date will be the first trading day following the 20th day of the month).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.